Table 1 Demographic and clinicopathological data in HCC patients

Gender, male/female (%)

183 (77.9%)/52 (22.1%)

Age,≤60 years/>60 years(%)

143 (60.9)/92 (39.1)

Diabetes mellitus (%)

50 (21.3%)

High blood pressure (%)

64 (27.2%)

History of smoking (%)

98 (41.7%)

History of drinking (%)

76 (32.3%)

Cirrhosis (%)

180 (76.6%)

Child-Pugh class, A/B (%)

154 (65.5%)/81 (34.5%)

Antiviral therapy (%)

124 (52.8%)

Tumor number, solitary/multiple (%)

167 (71.1%)/68 (28.9%)

Tumor size, <30 mm vs ≥30 mm

154 (65.5%)/81 (34.5%)

Ablation method, RFA/MWA/AHC (%)

117 (49.8%)/61 (26%)/57 (24.3%)

Etiology, HBV/HCV/ALD (%)

177 (75.3%)/43 (18.3%)/15 (6.4%)

AFP (< 7 ng/mL/7-400 ng/mL/≥400 ng/mL)

107 (45.5%)/99 (42.1%)29 (12.4%)

Viral load(< 100 IU/mL/≥100 IU/mL)

139 (59.1%)/96 (40.9%)

ALT(U/L)

37.82 ± 20.40

AST(U/L)

32.59 ± 12.62

Total serum bilirubin (mg/dL)

19.16 ± 9.46

Neutrophil count (10^9/L)

3.26 ± 1.64

Lymphocyte count (10^9/L)

1.22 ± 0.57

Platelet count (10^9/L)

125.15 ± 64.62

Albumin(g/L)

36.89 ± 4.68

Globulin(g/L)

27.92 ± 6.50

Fibrinogen (mg/dL)

2.93 ± 0.93

GPR

0.70 ± 1.01